NFCR Molecular Imaging Center
Case Center for Imaging Research
Case Western Reserve University School of Medicine, Department of Radiology Wearn Buidling, B41
Jeff Duerk, PhD, Facility Director
Christopher Flask, PhD, Director, Scientific Operations
James Basilion, PhD, Core Director
Contact:
Serves: Resource for all scientific investigators in the Northeastern Ohio region and beyond and to external researchers through sponsored research agreements
Overview
Case Center for Imaging Research, a joint venture between Case Western Reserve University School of Medicine and University Hospitals of Cleveland, extends the strategies that have led to successes in bringing novel imaging technologies to the CWRU campus, expands interdepartmental collaboration and interdisciplinary research and facilitates CWRU’s becoming an emerging leader in imaging research. CCIR promotes intensive interaction between faculty, students and outside investigators by providing a collaborative environment through its state-of-the-art facilities and access to the latest in imaging technology.
A major part of the Center for Imaging Research includes state-of-the-art clinical and preclinical research imaging facilities including 4 new multi-nuclear, high-field MRI systems, 4 nuclear imaging systems, and 2 optical imaging systems. Centrally located in basement of Lerner Tower, ~9000 sq. foot facility also includes wet labs, conference areas, and additional faculty office space. CCIR serves as a core for the Cystic Fibrosis Center (Animal Imaging Core), the Case Comprehensive Cancer Center (Imaging Research Core), the Center for Stem Cell and Regenerative Medicine (Imaging Core). The National Foundation for Cancer Research has established a Molecular Imaging Center as part of the Case Center for Imaging Research under the direction of Dr. James Basilion. This center concentrates on research related to the development and application of Molecular Imaging technologies. Specifically, we are interested in designing novel imaging tools to image individual and multiple molecular markers of disease. We believe that imaging tissues based on the underlying molecular rather than macromolecular differences will result in a substantial increase in the sensitivity and specificity of medical imaging. Some areas of active research include defining “molecular signatures” of disease, developing paradigms to image multiple markers of disease simultaneously, developing methods to image intracellular disease markers in breast cancer, and developing molecular imaging technologies that allow for intraoperative assessment of disease progression.
Page last updated: October, 2007
 |
216-983-3264
